Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Retained Earnings: 2009-2025

Historic Retained Earnings for Gyre Therapeutics (GYRE) over the last 17 years, with Sep 2025 value amounting to -$66.7 million.

  • Gyre Therapeutics' Retained Earnings rose 9.12% to -$66.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.7 million, marking a year-over-year increase of 9.12%. This contributed to the annual value of -$73.5 million for FY2024, which is 14.13% up from last year.
  • Latest data reveals that Gyre Therapeutics reported Retained Earnings of -$66.7 million as of Q3 2025, which was up 5.13% from -$70.3 million recorded in Q2 2025.
  • Gyre Therapeutics' 5-year Retained Earnings high stood at $7.4 million for Q4 2022, and its period low was -$417.2 million during Q1 2022.
  • Its 3-year average for Retained Earnings is -$166.5 million, with a median of -$74.5 million in 2024.
  • Its Retained Earnings has fluctuated over the past 5 years, first spiked by 101.84% in 2022, then slumped by 1,256.70% in 2023.
  • Gyre Therapeutics' Retained Earnings (Quarterly) stood at -$402.7 million in 2021, then spiked by 101.84% to $7.4 million in 2022, then slumped by 1,256.70% to -$85.5 million in 2023, then climbed by 14.13% to -$73.5 million in 2024, then increased by 9.12% to -$66.7 million in 2025.
  • Its Retained Earnings stands at -$66.7 million for Q3 2025, versus -$70.3 million for Q2 2025 and -$70.8 million for Q1 2025.